Stumvoll, M
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
These effects are often more pronounced during the initial stages of treatment as the body adjusts to the medication
The MHRA and EMA have concluded that current evidence does not support a causal association between these medications and pancreatic cancer
When to choose Ritalin vs Aderall Its hard to know exactly which one will work for you, but some signs that Ritalin could fit are if you: Want flexibility with dosing Dont need all-day coverage Are sensitive to stimulation or anxiety Prefer a milder, more controllable effect Otherwise, you might lean toward Adderall if you: Need longer-lasting focus Want fewer dosing decisions during the day Have tried methylphenidate without success Struggle more with motivation than distraction Side Effects Common to Both Medications Since both are stimulants, you can expect some similar side effects, including: Nausea Dry mouth Headaches Trouble sleeping Increased heart rate Nervousness, irritability, anxiety After a few weeks of adjusting, most of these side effects tend to dissipate